Clinical Trials Directory

Trials / Completed

CompletedNCT00158184

Prescription Opioid Effects in Abusers Versus Non-Abusers

Prescription Opioid Effects in Drug and Non-drug Abusers - 1

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
27 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the abuse liability of oxycodone in individuals with, and without, a history of prescription opioid abuse.

Detailed description

Prescription opioid abuse is becoming an increasingly widespread and serious public health concern. The 2001 National Household Survey on Drug Abuse report revealed that the number of first-time users of prescription opioid medications for non-medical reasons reached 2 million in the year 2000, a number that has quintupled since 1984. Despite this trend, little experimental research has been directed towards understanding who may be abusing these medications, and under what conditions. The study will examine the reinforcing, subjective, performance, and physiological effects of oxycodone. Because it is not clear who is abusing prescription opioids, the medication effects will be compared in drug abusers and non-drug abusers.

Conditions

Interventions

TypeNameDescription
DRUGoxycodone 15 mg15 mg/70 kg oxycodone administered once per day, orally.
DRUGoxycodone 30 mg30 mg/70 kg oxycodone administered once per day, orally.
DRUGPlacebo 0 mg0 mg placebo dose administered once a day, orally.

Timeline

Start date
2004-06-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2005-09-12
Last updated
2017-07-07
Results posted
2017-07-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00158184. Inclusion in this directory is not an endorsement.